Cite

HARVARD Citation

    Zhu, X. et al. (2019). Synergy between dihydromyricetin intervention and irinotecan chemotherapy delays the progression of colon cancer in mouse models. Food & function. 10 (4), pp. 2040-2049. [Online]. 
  
Back to record